BuyMeWhiskey.comStock analysisAnswersIVA news
Home › Stock analysis › IVA

Inventiva (IVA) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

IVA jumps 8.4% to $3.11. Closed at $3.11, +8.36% vs the prior close of $2.87. Day range $2.93–$3.18, opened at $2.97.

Last close$3.11+8.36%
Day range2.93–3.18
Open2.97
Volume2.91M
52-week range2.82–7.98
Avg volume (20d)2.89M

IVA daily analysis — what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 — IVA jumps 8.4% to $3.11
Oct 14, 2026 — IVA ends flat (+0.0%) to $2.87 on 1.9x normal volume
Oct 13, 2026 — IVA slides 8.0% to $2.87, a 52-week low, 7 down days in a row
Oct 12, 2026 — IVA dips 1.3% to $3.12, a 52-week low on 2.1x normal volume
Oct 9, 2026 — IVA slides 4.8% to $3.16, a 52-week low on 1.8x normal volume
Oct 8, 2026 — IVA dips 1.3% to $3.32, 4 down days in a row
Oct 7, 2026 — IVA dips 2.7% to $3.37, 3 down days in a row
Oct 6, 2026 — IVA dips 0.6% to $3.46
Oct 5, 2026 — IVA dips 2.2% to $3.48
Oct 2, 2026 — IVA rises 2.9% to $3.56 on 3.6x normal volume

IVA latest news & SEC filings

Every SEC filing by or about IVA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 6, 2026 · 6-K — Report from a foreign company (6-K)

Report from a foreign company (6-K) — news it published at home

Source: SEC EDGAR filing 0001171843-26-006471

Sep 28, 2026 · 6-K — Report from a foreign company (6-K)

Report from a foreign company (6-K) — news it published at home

Source: SEC EDGAR filing 0001104659-26-111143

Sep 3, 2026 · 6-K — Report from a foreign company (6-K)

Report from a foreign company (6-K) — news it published at home

Source: SEC EDGAR filing 0001171843-26-005860

Sep 1, 2026 · 6-K — Report from a foreign company (6-K)

Report from a foreign company (6-K) — news it published at home

Source: SEC EDGAR filing 0001171843-26-005810

Jul 30, 2026 · 6-K/A — 6-K/A filing

6-K/A filing

Source: SEC EDGAR filing 0001171843-26-005090

Jul 29, 2026 · 6-K — Report from a foreign company (6-K)

Report from a foreign company (6-K) — news it published at home

Source: SEC EDGAR filing 0001171843-26-005018

Jul 9, 2026 · 6-K — Report from a foreign company (6-K)

Report from a foreign company (6-K) — news it published at home

Source: SEC EDGAR filing 0001171843-26-004554

Jul 6, 2026 · 6-K — Report from a foreign company (6-K)

Report from a foreign company (6-K) — news it published at home

Source: SEC EDGAR filing 0001171843-26-004459

Things to know before you trade IVA

IVA market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 15, 20262.973.182.933.112.91M
Oct 14, 20262.872.962.822.873.15M
Oct 13, 20263.023.042.872.872.51M
Oct 12, 20263.253.273.103.123.26M
Oct 9, 20263.353.353.153.162.79M
Oct 8, 20263.343.393.163.322.17M
Oct 7, 20263.463.463.283.372.40M
Oct 6, 20263.533.543.293.462.20M
Oct 5, 20263.523.533.383.481.70M
Oct 2, 20263.573.643.463.564.89M
Oct 1, 20263.383.763.363.465.32M
Sep 30, 20263.513.923.463.694.80M
Sep 29, 20263.493.543.273.293.83M
Sep 28, 20263.273.623.213.533.48M
Sep 25, 20263.203.433.163.373.00M
Sep 24, 20263.383.383.113.262.37M
Sep 23, 20263.583.583.403.452.13M
Sep 22, 20263.563.673.483.652.56M
Sep 21, 20263.703.703.573.651.37M
Sep 18, 20263.793.823.663.781.05M

About Inventiva

Inventiva (IVA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in DAIX, France. State of incorporation: France. Fiscal year ends December 31. SEC CIK 1756594.

IVA board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

IVA financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $—, total liabilities $—, cash $—.

IVA earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks · Pharmaceutical Preparations

Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)

Popular today

Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)

More on IVA

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.